Previous 10 | Next 10 |
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Masimo To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - August 27, 2023) - Faruqi & Faruqi, LLP, a leading national securities law firm, is i...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Masimo To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - August 25, 2023) - Faruqi & Faruqi, LLP, a leading national securities law firm, is i...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Masimo To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - August 24, 2023) - Faruqi & Faruqi, LLP, a leading national securities law firm, is i...
Masimo (NASDAQ: MASI), a global leader in noninvasive monitoring technologies, today announced the full U.S. market release of the Stork smart home baby monitoring system. Stork Vitals+, Vitals, and Camera combinations are now available for purchase online at www.MasimoStork.com and on shel...
Researchers Found That Fluid Therapy Guided by Noninvasive, Continuous PVi Reduced Cardiopulmonary Complications and Fluid Administered Masimo (NASDAQ: MASI) today announced the findings of a prospective, randomized study published in Perioperative Medicine in which Dr. Yu Wang ...
2023-08-08 21:59:07 ET Masimo Corporation (MASI) Q2 2023 Earnings Conference Call August 08, 2023, 16:30 ET Company Participants Eli Kammerman - VP, Business Development & IR Joseph Kiani - Founder, CEO & Chairman Micah Young - EVP & CFO Confere...
2023-08-08 16:19:18 ET Masimo press release ( NASDAQ: MASI ): Q2 Non-GAAP EPS of $0.62 misses by $0.02 . Revenue of $455.3M (-19.5% Y/Y) misses by $12.4M . For the healthcare segment, third-quarter 2023 revenue guidance includes year-over-year foreign currency ...
Second Quarter 2023 Highlights Consolidated revenue was $455.3 million; Healthcare revenue was $281.1 million; Non-healthcare revenue was $174.2 million; GAAP net income per diluted share was $0.29; and Non-GAAP net income per diluted share was $0.62. Masimo Corp...
2023-08-08 08:16:20 ET Summary Masimo Corporation faces competition in the healthcare equipment industry and its valuation may be getting out of hand. The company's preliminary results for Q2 2023 were below expectations, leading to a significant decline in share price. Margin...
Masimo PSi, a Processed EEG Parameter, “Better Captured” Changes in Brain State Compared to Other Assessment Methods Masimo (NASDAQ: MASI) today announced the findings of a study published in Frontiers in Neuroscience in which Dr. Lichy Han and colleagues at Stanfo...
News, Short Squeeze, Breakout and More Instantly...
Conference call and webcast to begin at 1:30 p.m. PT (4:30 p.m. ET) Masimo (NASDAQ: MASI) will release second quarter 2024 financial results for the period ended March 30, 2024, after the market closes on Tuesday, August 6, 2024. The conference call to review the results will begin at 1...
Politan Will Take All Necessary Action to Ensure That the Annual Meeting Is Not Delayed Any Further Beyond September 19 and Hopefully Is Held Sooner Politan Capital Management (together with its affiliates, “Politan”), an 8.9% shareholder of Masimo Corporation (“Mas...
Masimo Corporation (“Masimo” or the “Company”) (Nasdaq: MASI), a global leader in noninvasive monitoring technologies and audio products, today announced that it has commenced litigation against Politan Capital Management LP (“Politan”) in federal court i...